Ikarisoside B is a potent and selective Organic cation transporter 1 ( OCT1 ) inhibitor with an IC 50 of 11.18 μM. Ikarisoside B shows selectivity over OCT2 ( IC 50 = 56.54 μM). Ikarisoside B can be used for the research of metabolic disease .
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Research Areas > Metabolic Disease
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.